Nicholas M. Ruge

False Claims Act

• U.S. ex rel. Schutte v. Supervalu & U.S. ex rel. Proctor v. Safeway: After taking over the eight-year-old cases as trial counsel, won complete dismissal of two False Claims Act suits with billions of dollars at issue by identifying a new defense and filing supplemental summary judgment motions.
• U.S. ex rel. LaFauci v. AbbVie & U.S. ex rel. Miller v. AbbVie: Obtained dismissal with prejudice of all claims in False Claims Act suits alleging Anti-Kickback Statute violations in connection with patient support services.

Restructuring

• In re J. C. Penney Company, Inc.: Represented J. C. Penney Company, Inc. and 17 of its affiliates in their successful pre-arranged chapter 11 cases that addressed more than $8 billion in liabilities.
  • Secured $450 million in new money debtor-in-possession financing as trial counsel for the debtors in contested financing proceedings.
  • Trial counsel for the debtors in contested hearings that resulted in the sale of the company’s operating assets, ensuring the survival of the company and preservation of more than 60,000 jobs.
    

Antitrust

• In re Pork Antitrust Litigation: Representing Clemens Family Corporation in antitrust class action seeking treble damages for alleged conspiracy to raise pork prices by reducing supply and exchanging competitively sensitive information among pork producers.

Securities and Shareholder Litigation

• Holwill v. AbbVie: Representing AbbVie, its CEO, and its former CFO in securities fraud class action regarding sales and marketing of Humira.
• Defended a Fortune 100 pharmaceutical company and its directors in a shareholder derivative suit arising out of the company's stock buyback and alleged blockbuster drug kickback scheme. Won on motion to dismiss.

Commercial Litigation

• Won temporary restraining order against multinational chain of beauty stores, preventing the unilateral termination of a decade-long joint enterprise operating agreement. Resulted in favorable contract renegotiation for client.
• AbbVie/Shire State Cases: Representing AbbVie and its CEO against hedge funds alleging fraud in connection with the company’s termination of its $50 billion agreement to acquire Shire plc.
• Counsel medical device manufacturer on litigation related to former employee’s violation of non-compete agreement.

Investigations and Enforcement

• Counsel medical device company on regulatory compliance issues related to COVID-19 testing.
• Represented medical device company in negotiations with the Food and Drug Administration regarding labeling of medical device product.
• Represented company in federal investigation involving alleged violations of the Bank Secrecy Act and Anti-Money Laundering regulations.
• Counseled AbbVie in its $63 billion acquisition of Allergan.
• Counseled major league sports team on negotiations with local government over pending regulations.

Represented plaintiffs in Karnoski v. Trump, a constitutional challenge to the Trump administration’s ban on transgender military service. Obtained landmark ruling at Ninth Circuit finding transgender-based classifications subject to heightened scrutiny. For his work on the case, including before the United States Supreme Court, Nick received Kirkland’s Pro Bono Service Award and Pro Bono All Star Award.

Represented South Shore Chamber, Inc., a nonprofit that promotes economic development in south Chicago, in appeal of administrative order requiring the nonprofit to repay state grant funds based on alleged accounting errors. Won judgment for South Shore on appeal, ending six years of prior litigation.